Convelo Therapeutics
Cleveland
About Convelo Therapeutics
Convelo Therapeutics specializes in developing medicines to regenerate myelin around nerve cells and restore function. The company's scientists have developed an innovative platform to identify novel candidate treatments capable of directly stimulating stem cells in the central nervous system to form new myelin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $20.6M
- Last round: Series Unknown (Dec 2022)
- Website: convelotx.com
- Phone: 216-658-3969
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/convelo-therapeutics-61253 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.